Adjuvant intravesical bacillus Calmette-Guérin therapy and survival among elderly patients with non-muscle-invasive bladder cancer
Urinary Bladder Neoplasms
Despite guidelines recommending its use, BCG is administered to less than one quarter of eligible patients. This large population-based study found improved OS and BCSS were associated with use of adjuvant intravesical BCG among older patients with NMIBC. Better-designed clinical trials focusing on higher-grade cancers are needed to confirm these findings.